Evolent Health Q4 EPS $0.23 Beats $0.15 Estimate, Sales $556.05M Beat $542.39M Estimate
Portfolio Pulse from Happy Mohamed
Evolent Health (EVH) reported Q4 earnings of $0.23 per share, surpassing the consensus estimate of $0.15 by 53.33%. Year-over-year, earnings increased by 130% from $0.10 per share. Q4 sales reached $556.05M, exceeding estimates of $542.39M by 2.52% and marking a 45.40% increase from the previous year's $382.43M.
February 22, 2024 | 9:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Evolent Health reported a significant beat on both earnings and sales estimates for Q4, with a 130% increase in EPS YoY and a 45.40% increase in sales YoY.
The substantial beat on both earnings per share and sales estimates, coupled with significant year-over-year growth, is likely to positively influence investor sentiment and drive short-term stock price appreciation. The company's performance exceeds analyst expectations, indicating strong operational efficiency and market demand for its services.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100